1. Predictive Value of KDM5C Alterations for Immune Checkpoint Inhibitors Treatment Outcomes in Patients With Cancer
   Xiao-Juan Chen et al, 2021, Front. Immunol. CrossRef
2. BRCA1-Associated Protein 1 (BAP-1) as a Prognostic and Predictive Biomarker in Clear Cell Renal Cell Carcinoma: A Systematic Review
   Shuchi Gulati et al, 2021, KCA CrossRef
3. Identification of Survival-Specific Genes in Clear Cell Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel
   Jia Hwang et al, 2022, JPM CrossRef
4. New insights into fibrotic signaling in renal cell carcinoma
   Jiao-Yi Chen et al, 2023, Front. Cell Dev. Biol. CrossRef
5. Exploring the anticancer potential of hydrogen sulfide and BAY‑876 on clear cell renal cell carcinoma cells: Uncovering novel mutations in VHL and KDR genes among ccRCC patients
   Peshraw Hamadamin et al, 2024, Mol Clin Oncol CrossRef
6. The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma
   Priyanka Naik et al, 2024, Therapeutic Advances in Urology CrossRef
7. Identification of key genes and signalling pathways in clear cell renal cell carcinoma: An integrated bioinformatics approach
   Vinoth S et al, 2024, CBM CrossRef
8. Targeted Therapy with Polymeric Nanoparticles in PBRM1-Mutant Biliary Tract Cancers: Harnessing DNA Damage Repair Mechanisms
   Hrushikesh Wagh et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
9. Whole-Exome Sequencing Reveals Novel Candidate Driver Mutations and Potential Druggable Mutations in Patients with High-Risk Neuroblastoma
   Natakorn Nokchan et al, 2024, JPM CrossRef
10. MMIST-ccRCC: A Real World Medical Dataset for the Development of Multi-Modal Systems
    Tiago Mota et al, 2024 CrossRef